Literature DB >> 25178264

Influence of early surgical treatment on the prognosis of left-sided infective endocarditis: a multicenter cohort study.

Juan Gálvez-Acebal1, Manuel Almendro-Delia2, Josefa Ruiz3, Arístides de Alarcón4, Francisco J Martínez-Marcos5, José M Reguera6, Radka Ivanova-Georgieva3, Mariam Noureddine7, Antonio Plata6, José M Lomas5, Javier de la Torre-Lima7, Carmen Hidalgo-Tenorio8, Rafael Luque4, Jesús Rodríguez-Baño9.   

Abstract

OBJECTIVE: To analyze the influence of early valve operation on mortality in patients with left-sided infective endocarditis (IE). PATIENTS AND METHODS: A multicenter cohort study was carried out between 1990 and 2010. Data from consecutive patients with definite IE and possible left-sided IE were collected. Propensity score matching and adjustment for survivor bias were used to control for confounders. The primary outcome was in-hospital mortality.
RESULTS: A total of 1019 patients with a mean age of 61 years (interquartile range, 47-71 years) were included. Early surgical treatment was performed in 417 episodes (40.9%). By propensity score, we matched 316 episodes: 158 who underwent early surgical treatment and 158 who did not (medical treatment group). In-hospital mortality and late mortality were lower in the surgically treated group (26.6% vs 41.8%; absolute risk reduction [ARR], -15.2%; P=.004 and 29.7% vs 46.2%; ARR, -16.5%; P=.002, respectively). Operation was independently associated with a lower risk of in-hospital mortality (odds ratio, 0.42; 95% CI, 0.22-0.79; P=.007). Operation was associated with reduced mortality in patients with paravalvular complications (ARR, -40.5%), severe heart failure (ARR, -32%), and native valve endocarditis (ARR, -17.8%).
CONCLUSION: This study supports the benefit of surgical treatment in patients with left-sided IE carried out during the initial phase of hospitalization, especially in patients with moderate or severe heart failure and paravalvular extension of infection.
Copyright © 2014 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25178264     DOI: 10.1016/j.mayocp.2014.06.021

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  10 in total

1.  Zolpidem improves patients' sleep quality after surgical treatment for infective endocarditis: a prospective observational study.

Authors:  Xiangming Hu; Deyi Huang; Caidi Lin; Xiaoming Li; Fen Lu; Wenting Wei; Zhihong Yu; Huosheng Liao; Fang Huang; Xuezhen Huang; Fujun Jia
Journal:  Sleep Breath       Date:  2021-08-27       Impact factor: 2.655

2.  Sleep patterns and potential risk factors for disturbed sleep quality in patients after surgery for infective endocarditis.

Authors:  Xiang-Ming Hu; Wen-Ting Wei; De-Yi Huang; Cai-Di Lin; Fen Lu; Xiao-Ming Li; Huo-Sheng Liao; Zhi-Hong Yu; Xiao-Ping Weng; Shi-Bin Wang; Cai-Lan Hou; Fu-Jun Jia
Journal:  J Cardiothorac Surg       Date:  2022-05-17       Impact factor: 1.522

3.  Multimodality imaging in a diagnostic and therapeutic process of a patient with infective endocarditis.

Authors:  Maria Binkiewicz-Orluk; Marcin Konopka; Katarzyna Sierakowska-Sitkiewicz; Wojciech Król; Leszek Królicki; Marek Kuch; Wojciech Braksator
Journal:  J Ultrason       Date:  2020-03-31

4.  Iranian Registry of Infective Endocarditis (IRIE): Time to relook at the guideline, regarding to regional differences.

Authors:  Anita Sadeghpour; Majid Maleki; Massoud Movassaghi; Leila Rezvani; Feridoun Noohi; Shabnam Boudagh; Behshid Ghadrdoost; Hooman Bakhshandeh; Azin Alizadehasl; Nasim Naderi; Monireh Kamali; Alireza A Ghavidel; Mohammad Mahdi Peighambari; Majid Kyavar; Hamidreza Pasha
Journal:  Int J Cardiol Heart Vasc       Date:  2019-11-07

Review 5.  A management framework for left sided endocarditis: a narrative review.

Authors:  Francesco Nappi; Cristiano Spadaccio; Marc R Moon
Journal:  Ann Transl Med       Date:  2020-12

Review 6.  A narrative review of early surgery versus conventional treatment for infective endocarditis: do we have an answer?

Authors:  Umberto Benedetto; Cristiano Spadaccio; Federico Gentile; Marc R Moon; Francesco Nappi
Journal:  Ann Transl Med       Date:  2020-12

Review 7.  Guidelines on prosthetic heart valve management in infective endocarditis: a narrative review comparing American Heart Association/American College of Cardiology and European Society of Cardiology guidelines.

Authors:  Umberto Maria Satriano; Antonio Nenna; Cristiano Spadaccio; Francesco Pollari; Theodor Fischlein; Massimo Chello; Francesco Nappi
Journal:  Ann Transl Med       Date:  2020-12

8.  Current Epidemiology and Outcome of Infective Endocarditis: A Multicenter, Prospective, Cohort Study.

Authors:  Patricia Muñoz; Martha Kestler; Arístides De Alarcon; José María Miro; Javier Bermejo; Hugo Rodríguez-Abella; Maria Carmen Fariñas; Manuel Cobo Belaustegui; Carlos Mestres; Pedro Llinares; Miguel Goenaga; Enrique Navas; José Antonio Oteo; Paola Tarabini; Emilio Bouza
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

9.  Combined efficacy of C-reactive protein and red blood cell distribution width in prognosis of patients with culture-negative infective endocarditis.

Authors:  Xue-Biao Wei; Yuan-Hui Liu; Peng-Cheng He; Ying-Ling Zhou; Ning Tan; Ji-Yan Chen; Dan-Qing Yu
Journal:  Oncotarget       Date:  2017-04-06

10.  Surgical procedure versus medical treatment for infective endocarditis associated to mortality in Mexican population.

Authors:  José A Alvarado-Alvarado; Gildardo Vidal-Morales; Ricardo I Velázquez-Silva; Arturo Ortiz-Álvarez; Rodrigo Torres-Velázquez; Jesús D Velázquez-Orta; Martín Magaña-Aquino; Marco U Martínez-Martínez
Journal:  Arch Cardiol Mex       Date:  2021-11-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.